Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12R - Indexing scheme associated with subclasses , relating to micro-organisms › C12R 1 - Micro-organisms
Patents for C12R 1 - Micro-organisms (92,025)
03/2003
03/26/2003EP1295937A2 Candida boidinii formic hydrogenase mutants
03/26/2003EP1295527A1 Mouse showing neurofibril change due to senile dementia
03/26/2003EP1294939A2 Detection and typing of human papillomavirus using pna probes
03/26/2003EP1294863A2 Detection of rna
03/26/2003EP1294852A1 Enhanced flavour production in or relating to food by cultivation of various food-grade micro-organisms
03/26/2003EP1294767A1 Low oxygen affinity mutant hemoglobins
03/26/2003EP1294753A2 A human homologue of the db4/ask1 protein, nucleic acids, and methods related to the same
03/26/2003EP1294676A1 Novel compositions for isolating and/or stabilising nucleic acids in biological material
03/26/2003EP1165755A4 Banana and melon promoters for expression of transgenes in plants
03/26/2003EP1025052B1 Method for reducing the effect of detergents upon germination and/or growth of microorganisms
03/26/2003EP0870016B1 Enzymes, their preparation and their use in the production of ammonium acrylate
03/26/2003EP0625159B1 Ikaros: a regulatory gene involved in t-cell differentiation
03/26/2003EP0261224B2 Synthetic htlv-iii peptides, compositions and uses thereof
03/26/2003CN1406285A Method for detecting and quantifying adenovirus
03/26/2003CN1406281A Aspartate carbamyltransferase as herbicidal target
03/26/2003CN1406278A Expression of recombinant mature lysostaphin
03/26/2003CN1406275A Microorganism producing L-lysine and processes for producing L-lysine usi ng the same
03/26/2003CN1406274A Novel lactobacillus paracasei subsp. paracasei strain antibacterial against nelicobacter pylori and escherichia coli 157:H7
03/26/2003CN1406273A Microorganism producing 5'-inosinic acid and process for producing 5'-inosinic acid using the same
03/26/2003CN1405180A Chemotactic factor beta-8 short type
03/26/2003CN1404877A Blood-platelet specific mosaic immune globulin and its using method
03/26/2003CN1103820C Method for detection of methylthioadenosine phosphorylase deticiency in mammallian cells
03/26/2003CN1103812C Human beta-2 integrin alpha subunit
03/26/2003CN1103782C Mono-pegylated MGDF polypeptide
03/26/2003CN1103602C Process for preparing pharmaceutical formulation containing insulin analog
03/25/2003USRE38047 Soil microorganisms that produce a hemicellulase which is particularly useful in increasing the available energy in feeds; a mannanase
03/25/2003US6538127 Synthetic HIV-2 envelope genes containing modifications that lead to optimized expression in bacteria
03/25/2003US6538126 Polynucleotides of given sequence derived from CDNA
03/25/2003US6538121 Interleukin-1 β converting enzyme like apoptosis protease-3 and 4
03/25/2003US6538109 Polynucleotide compositions encoding broad spectrum delta-endotoxins
03/25/2003US6537812 Methods for the production of TcRγδ+ T cells
03/25/2003US6537809 Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
03/25/2003US6537795 Supercapsulated mutated strain of streptococcus from culture medium free of metal ions
03/25/2003US6537773 Open reading frames; gene expression; genetic vectors; computer based storage of sequence information; use detection and diagnosis of Mycoplasma
03/25/2003US6537770 Assay for detecting phospho-N-acetylmuramyl-pentapeptide translocase activity
03/25/2003US6537764 Method of identifying inhibitors of C—C chemokine receptor 3
03/25/2003US6537756 Bacillus thuringiensis CryET29 compositions toxic to coleopteran insects and Ctenocephalides SPP
03/25/2003US6537570 Method of biological control
03/25/2003US6537556 Peptide fragment of respiratory syncytial virus protein G, immunogenic agent, pharmaceutical composition containing it and preparation process
03/25/2003US6537551 Anti-tumor agent comprising salmosin as an active ingredient
03/25/2003US6537546 Process for macromolecularizing phenolic compounds etc. and use thereof
03/25/2003US6537544 Oatmeal gruel fermiented with strains of lactobacillus plantarum JI:1 and species AC:3; prophylaxis or treatment of disturbances in equine intestinal microflora and gastritis
03/25/2003CA2251262C Nucleic acid encoding a nervous tissue sodium channel
03/25/2003CA2232749C Truncated glial cell line-derived neurotrophic factor
03/25/2003CA2125783C Methods for producing thrombin
03/25/2003CA2123108C Human neuropeptide y-y1 receptor
03/25/2003CA2075681C Process for converting lipid-containing bacterial capsular polysaccharide into lipid-free polysaccharide
03/25/2003CA2075182C Retinoid receptor compositions and methods
03/25/2003CA2056102C Method for the production of antibodies
03/21/2003CA2404706A1 Novel mutants of the formate dehydrogenase from candida boidinii
03/20/2003WO2003023030A2 Aminopeptidase
03/20/2003WO2002088340A3 Alkaline protease variants and detergents and cleaning agents containing said alkaline protease variants
03/20/2003WO2002068603A9 Materials and methods for the induction of premature chromosome condensation
03/20/2003WO2002026961A3 Production process of surfactin
03/20/2003WO2002002811A3 Method for controlling the microbiological quality of an aqueous medium and kit therefor
03/20/2003WO2002002591A3 Peptides for use in culture media
03/20/2003WO2001073104A9 Beta-glucans from filamentous fungi
03/20/2003WO1999049294A3 Assay methods
03/20/2003US20030056229 Nucleotide sequences coding polypeptide for use in the treatment of leukemias, autoimmune and arthritic diseases
03/20/2003US20030055239 Human receptor tyrosine kinase, KDR
03/20/2003US20030055232 Nucleotide sequences coding enzymatic polypeptide for use in the generation of lysine
03/20/2003US20030054992 Therapy
03/20/2003US20030054554 Albumin derivatives with therapeutic functions
03/20/2003US20030054539 Enzymatic polypeptide for use in paper making, detergents and textile processing
03/20/2003US20030054525 UDP-N-acetylglucosamine: galactose-beta1,3-N-acetylgalactosamine-alpha-R / (GlcNAc to GalNAc) beta1,6-N-acetylglucosaminyltransferase, C2GnT3
03/20/2003US20030054520 Recombinant enzymes having improved NAD (H) affinity
03/20/2003US20030054518 Novel xylanase from trichoderma reesei, method for production thereof, and methods employing this enzyme
03/20/2003US20030054506 Method of producing L-lysine
03/20/2003US20030054504 Genetically engineered microorganism for use in the generation of 5'-inosinic acid
03/20/2003US20030054439 Truncated soluble tumor necrosis factor type-I and type-II receptors
03/20/2003US20030054436 Staphylococcus aureus polynucleotides and sequences
03/20/2003US20030054335 Cell culturing method and device
03/20/2003US20030054008 Mycobacterial proteins, microorganisms producing them and their use for vaccines and for the detection of tuberculosis
03/20/2003US20030053987 Synthetic hepatitis c genes
03/19/2003EP1293560A2 Methods for producing L-lysine and L-glutamic acid by fermentation
03/19/2003EP1293513A2 A recombinant human factor VIII derivative
03/19/2003EP1292689A1 Regulated gene expression in yeast and methods of use
03/19/2003EP1292687A2 Regulated antigen delivery system (rads) involving bacteria
03/19/2003EP1292672A1 Immobilizing carrier comprising a porous medium
03/19/2003EP1292668A2 Gene disruption methodologies in fungi for drug target discovery
03/19/2003EP1147063B1 Process for the treatment of waste water containing heavy metals
03/19/2003EP1034268A4 G-protein coupled receptors and uses therefor
03/19/2003EP1002122B1 Process for preparing amides
03/19/2003EP0937156B1 Preparation of d-amino acids by direct fermentative means
03/19/2003EP0910409A4 Recombinant constructs encoding t cell receptors specific for human hla-restricted tumor antigens
03/19/2003EP0876482B1 Il-13 receptor polypeptide
03/19/2003EP0783695B1 Cell tests and diagnostic kit for alzheimer's disease
03/19/2003EP0771868B1 Novel deaminoneuraminidase and process for producing the same
03/19/2003EP0745094B1 Superagonists and antagonists of human il-6, and method for their selection
03/19/2003EP0722463B1 Methods and composition for the modulation of host immune response to allergens
03/19/2003EP0711350B1 Clavulanic acid dehydrogenase, preparation and use for the production of clavulanic acid
03/19/2003EP0711348B1 Process for the efficient production of 7-adca via 3-(carboxyethylthio)propionyl-7-adca
03/19/2003EP0677104B1 Activin receptor-like kinases, proteins having serine threonine kinase domains and their use
03/19/2003EP0670904B1 Vector for the expression of therapy-relevant genes
03/19/2003EP0667902B1 Cdr grafted humanised chimeric t-cell antibodies
03/19/2003EP0595935B1 Papillomavirus Vaccine
03/19/2003EP0556333B1 Avirulent salmonella microbes comprising a mutation in the cdt gene and uses therefor
03/19/2003CN1404487A High purity lipopeptides, lipopeptide micelles, process for preparing same
03/18/2003US6534642 Isolated nucleic acid of given sequence encoding a protein; dysfunction of the human protein implicated in hyper/hypocalcemia, bone disorders, leukemia and cancer
03/18/2003US6534633 Polyspecific binding molecules and uses thereof
1 ... 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 ... 921